Literature DB >> 23536631

GITR-dependent regulation of 4-1BB expression: implications for T cell memory and anti-4-1BB-induced pathology.

Gloria H Y Lin1, Laura M Snell, Michael E Wortzman, Derek L Clouthier, Tania H Watts.   

Abstract

The TNFR family member 4-1BB plays a key role in the survival of activated and memory CD8 T cells. However, the mechanisms that regulate 4-1BB re-expression on memory CD8 T cells after Ag clearance are unknown. In unimmunized mice, ∼10% of CD8 CD44(hi) memory T cells in the bone marrow (BM) and liver express 4-1BB, with minimal 4-1BB expression in spleen and lymph node. IL-2, IL-15, and IL-7 are collectively dispensable for 4-1BB expression on the memory CD8 T cells. Rather, T cell-intrinsic glucocorticoid-induced TNFR-related protein (GITR) contributes to 4-1BB expression on CD8 T cells upon their entry into the BM or liver. Consistent with its role in regulation of 4-1BB, GITR is required on memory CD8 T cells for their persistence in vivo. These findings reveal site-specific effects of the BM and liver microenvironment on CD8 memory T cells. Previous work has demonstrated that 4-1BB agonists given to unimmunized mice induce splenomegaly, hepatitis, and other immune system anomalies. Moreover, severe liver pathology has been observed in a subset of anti-4-1BB-treated melanoma patients. Remarkably, the absence of GITR in mice almost completely abrogates cellular expansions, splenomegaly, and liver inflammation associated with anti-4-1BB agonist treatment of unimmunized mice. In contrast, lack of CD8 T cells selectively improves liver pathology, but not splenomegaly in the mice. Thus, the regulation of 4-1BB expression by GITR on CD8 T cells, as well as on other cells, contributes to the pathological effects of anti-4-1BB in unimmunized mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536631     DOI: 10.4049/jimmunol.1201854

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  The advantages of PD1 activating chimeric receptor (PD1-ACR) engineered lymphocytes for PDL1(+) cancer therapy.

Authors:  Xiaolong Tang; Qingguo Li; Yongqiang Zhu; Donghui Zheng; Jingjing Dai; Wenxuan Ni; Jia Wei; Yubao Xue; Ke Chen; Wei Hou; Chao Zhang; Xiaojun Feng; Yong Liang
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

2.  Maintenance of memory T cells in the bone marrow: survival or homeostatic proliferation?

Authors:  Francesca Di Rosa
Journal:  Nat Rev Immunol       Date:  2016-03-21       Impact factor: 53.106

Review 3.  Stimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies.

Authors:  Xue Han; Matthew D Vesely
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-20       Impact factor: 6.813

4.  Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers.

Authors:  Stephanie Dorta-Estremera; Renee L Chin; Gloria Sierra; Courtney Nicholas; Ananta V Yanamandra; Sita M K Nookala; Guojun Yang; Shail Singh; Michael A Curran; K Jagannadha Sastry
Journal:  Cancer Res       Date:  2018-07-27       Impact factor: 12.701

5.  c-IAP ubiquitin protein ligase activity is required for 4-1BB signaling and CD8(+) memory T-cell survival.

Authors:  Maria Letizia Giardino Torchia; Ivana Munitic; Ehydel Castro; Jasmin Herz; Dorian B McGavern; Jonathan D Ashwell
Journal:  Eur J Immunol       Date:  2015-07-07       Impact factor: 5.532

Review 6.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

7.  Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells.

Authors:  Il-Kyu Kim; Byung-Seok Kim; Choong-Hyun Koh; Jae-Won Seok; Jun-Seok Park; Kwang-Soo Shin; Eun-Ah Bae; Ga-Eun Lee; Hyewon Jeon; Jaebeom Cho; Yujin Jung; Daehee Han; Byoung S Kwon; Ho-Young Lee; Yeonseok Chung; Chang-Yuil Kang
Journal:  Nat Med       Date:  2015-08-17       Impact factor: 53.440

Review 8.  Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells.

Authors:  Simona Ronchetti; Erika Ricci; Maria Grazia Petrillo; Luigi Cari; Graziella Migliorati; Giuseppe Nocentini; Carlo Riccardi
Journal:  J Immunol Res       Date:  2015-04-15       Impact factor: 4.818

Review 9.  4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity.

Authors:  Todd Bartkowiak; Michael A Curran
Journal:  Front Oncol       Date:  2015-06-08       Impact factor: 6.244

10.  PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell-Driven Antitumor Immunity.

Authors:  Sarah L Buchan; Mohannad Fallatah; Stephen M Thirdborough; Vadim Y Taraban; Anne Rogel; Lawrence J Thomas; Christine A Penfold; Li-Zhen He; Michael A Curran; Tibor Keler; Aymen Al-Shamkhani
Journal:  Clin Cancer Res       Date:  2018-03-07       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.